Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider
Nykode Therapeutics ASA (NYKD) · publisert 8. november 2024 kl. 15:18 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Christian Åbyholm via Norda ASA | Styremedlem | Kjøp | 5 000 000 | 1,9172 NOK | 8. november 2024 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- 20241108 Attachment.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, November 8, 2024. Norda ASA has today acquired 5,000,000 shares in Nykode Therapeutics ASA at an average price of NOK 1.9172 per share. Christian Åbyholm is Chairman of the Board of Norda ASA and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Norda ASA holds 12,996,755 shares in Nykode Therapeutics ASA.
For further details, please see the attached form.